Search

everythinglearnresearchcommunity

for

Search:↓

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Baldness score can't be used to predict prostate size.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Aspergillus niger culture creates two finasteride derivatives with enzyme-inhibiting effects.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Higher PSA levels are linked to more hirsutism in women with PCOS.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Combining D-004 and finasteride is more effective at reducing prostate enlargement than using either alone.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

No treatment fully prevents hair loss from chemotherapy yet.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Zapoteca portoricensis extract may help protect against prostate issues and support liver and kidney health in rats.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Quercetin boosts hair follicle stem cell growth and survival in cashmere goats.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

KGF-1 135 is a stable and effective alternative for treating oral mucositis.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.